Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?

Journal of medical microbiology - 1 Jun 2016

Nabili Mojtaba, Shokohi Tahereh, Moazeni Maryam, Khodavaisy Sadegh, Aliyali Masoud, Badiee Parisa, Zarrinfar Hossein, Hagen Ferry, Badali Hamid

Abstract excerpt

Triazole antifungal agents are the mainstay of aspergillosis treatment. As highlighted in numerous studies, the global increase in the prevalence of triazole resistance could hamper the management of aspergillosis. In the present three-year study, 513 samples (213 clinical and 300 environmental samples) from 10 provinces of Iran were processed and screened in terms of azole resistance (4 and 1 mg l-1 of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Aspergillosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspergillus fumigatus

Share to Cytochrome P-450 Enzyme System

Share to Drug Resistance, Multiple, Fungal

Share to Itraconazole

Share to Voriconazole

Source

Identifiers

PMID: 27008655
DOI: 10.1099/jmm.0.000255

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?PMID 27008655Read ↗

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.Semantic proximity Read ↗

Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in AsiaSemantic proximity Read ↗

First azole-resistant Aspergillus fumigatus isolates with the environmental TR46 /Y121F/T289A mutation in Iran.Semantic proximity Read ↗

Triazole resistance surveillance in Aspergillus fumigatus.Semantic proximity Read ↗

Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.Semantic proximity Read ↗

Examination of cyp51A and cyp51B expression level of the first Polish azole resistant clinical Aspergillus fumigatus isolateSemantic proximity Read ↗

Azole-resistant Aspergillus fumigatus as an emerging worldwide pathogen.Semantic proximity Read ↗

Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles.Semantic proximity Read ↗

Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran.Semantic proximity Read ↗

Prevalence, mechanisms and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan.Semantic proximity Read ↗

Genome-Wide Association Analysis for Triazole Resistance in Aspergillus fumigatusSemantic proximity Read ↗

Epidemiological characteristics of invasive Aspergillus isolates: Morphology, drug susceptibility, and mutations in azole drug targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.